1-(3-Bromo-4-methylphenyl)-3,5-dimethyl-1H-pyrazole-4-carbaldehyde, 98%, 250mg

3-(4-BROMOPHENYL)-2-((TERT-BUTOXYCARBONYL)AMINO)PROPANOIC ACID, 95.0%, 1g

Menthyl acetate, 97%, 500mg

3,6-Di(2-pyridyl)-1,2,4,5-tetrazine>98.0%(HPLC)5g

Phase contrast Abbe condenser with slide for Plan PLPHi 10/S40 phase contrast infinity corrected objectives, slide with 10 and 40x phases, telescope and green filter

1-Fluoro-4-(hexyloxy)-2-methylbenzene, 98%, 10g

TERT-BUTYL 5,5-DIMETHYL-1,2,3-OXATHIAZOLIDINE-3-CARBOXYLATE 2,2-DIOXIDE, 97.0%, 10g

4-CHLORO-8-ISOPROPYL-2-METHYLSULFANYL-PYRAZOLO[1,5-A][1,3,5]TRIAZINE, 90.0%, 500mg

2-Chloro-6-methylbenzoic acid, 98.0%, 5g

1-(tert-Butyl) 3-ethyl (3S,4R)-4-aminopiperidine-1,3-dicarboxylate, 98%, 1g

Dimethyl 3-aminothiophene-2,5-dicarboxylate, 98%, 250mg

(R)-Methyl morpholine-3-carboxylate, 95.0%, 1g

GC capillary column ROTI®Cap-1, 25 m, 0.32 mm, 0.10 µm, 1 Piece(s)